Literature DB >> 15519171

Synthesis and topoisomerase I inhibitory properties of luotonin A analogues.

Ali Cagir1, Brian M Eisenhauer, Rong Gao, Shannon J Thomas, Sidney M Hecht.   

Abstract

Luotonin A, a naturally occurring pyrroloquinazolinoquinoline alkaloid, has been previously demonstrated to be a topoisomerase I poison. A number of luotonin A derivatives have now been prepared through the condensation of anthranilic acid derivatives and 1,2-dihydropyrrolo[3,4-b]quinoline-3-one in the presence of phosphorus oxychloride. When dichloromethane was used as solvent the reaction proceeded to a single product. In contrast when the reaction was carried out in tetrahydrofuran or in phosphorus oxychloride, an additional isomeric product was obtained. The luotonin A analogues were evaluated for their ability to effect stabilization of the covalent binary complex formed between human topoisomerase I and DNA, and for cytotoxicity toward a yeast strain expressing the human topoisomerase I.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519171     DOI: 10.1016/j.bmc.2004.08.052

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.

Authors:  Maris A Cinelli; Andrew Morrell; Thomas S Dexheimer; Evan S Scher; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2008-07-17       Impact factor: 7.446

2.  A theoretical study of some new analogues of the anti-cancer drug camptothecin.

Authors:  Nihar R Jena; Phool C Mishra
Journal:  J Mol Model       Date:  2006-10-06       Impact factor: 1.810

3.  Oxone promoted dehydrogenative Povarov cyclization of N-aryl glycine derivatives: an approach towards quinoline fused lactones and lactams.

Authors:  Devidas A More; Ganesh H Shinde; Aslam C Shaikh; M Muthukrishnan
Journal:  RSC Adv       Date:  2019-09-25       Impact factor: 4.036

4.  Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.

Authors:  Sivappa Rasapalli; Vamshikrishna Reddy Sammeta; Zachary F Murphy; James A Golen; Keli Agama; Yves Pommier; Sergey N Savinov
Journal:  Bioorg Med Chem Lett       Date:  2021-03-30       Impact factor: 2.940

Review 5.  Recent advances in the studies on luotonins.

Authors:  Jing Lu Liang; Hyo Chang Cha; Yurngdong Jahng
Journal:  Molecules       Date:  2011-06-14       Impact factor: 4.411

6.  Weinreb amidation as the cornerstone of an improved synthetic route to A-ring-modified derivatives of luotonin A.

Authors:  Norbert Haider; Simon Nuß
Journal:  Molecules       Date:  2012-09-25       Impact factor: 4.411

7.  D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.

Authors:  Abdulrahman I Almansour; Raju Suresh Kumar; Natarajan Arumugam; Giulia Bianchini; J Carlos Menéndez; Faruq Mohammad; Kotresha Dupadahalli; Mohammad Altaf
Journal:  Biomed Res Int       Date:  2019-11-13       Impact factor: 3.411

8.  A Facile Oxidative Opening of the C-Ring in Luotonin A and Derivatives.

Authors:  Amra Ibric; Kathrin Dutter; Brigitte Marian; Norbert Haider
Journal:  Molecules       Date:  2017-09-12       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.